This simple blood test, potentially can assess your individual risk for developing lung cancer prior to the appearance of symptoms.
Professor John Robertson, MD -
The Inspiration Behind EarlyCDT
"The test can be paradigm-changing as a result of the technology that Oncimmune has developed."
Thomas Schmidt, MD, Indianapolis, IN
Careers With a Cause
Oncimmune (USA) LLC
8960 Commerce Drive, Building #6
De Soto, Kansas 66018
(888) 583-9030
Oncimmune (USA) LLC | 8960 Commerce Drive Building #6 | De Soto, Kansas 66018 | 888.583.9030